NLRP3 and type 2 diabetes mellitus: The serum NLRP3 concentration in the LEAD group in this study was significantly greater than that in the T2DM group, suggesting that the development of lower limb atherosclerotic lesions combined with T2DM may be related to the increased expression of NLRP3.